Cold Chain Planning: An Integrated Approach

December 03, 2016

CAR T-cell therapy, immunotherapy and other autologous cellular therapies require an integrated approach for their manufacture, shipment and storage. The need for integration is largely due to the complexity of the process for these therapeutics, where patient scheduling plays a key role in the timing and sequencing of shipments. In a Pharmaceutical Manufacturing article, Mark W. Sawicki, Ph.D., chief commercial officer of Cryoport, discusses how integrated logistics systems can provide solutions for optimizing shipments, monitoring the condition as well as the location of materials and coordinating purpose-built packaging. Read more >

Questions or comments? We welcome your feedback!

Email Us

Tags: Clinical Trials Logistics, Temperature Controlled Logistics, Frozen Biological Shipping

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC